96 institutions reported holding $180.5M of LYELL IMMUNOPHARMA INC (LYEL) in SEC 13F filings for 2026-06-30. Largest institutional holders: ARCH Venture Management, LLC ($45.5M), GSK plc ($21.3M), VANGUARD GROUP INC ($13.7M), Orland Properties Ltd ($10.6M), BlackRock, Inc. ($10.2M). Source: SEC Form 13F.
Source: SEC Form 13F filings · as of 2026-06-30